Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited
GZPHF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $74,993 | $75,515 | $70,788 | $69,014 |
| % Growth | -0.7% | 6.7% | 2.6% | – |
| Cost of Goods Sold | $62,473 | $61,328 | $57,511 | $55,781 |
| Gross Profit | $12,520 | $14,187 | $13,277 | $13,233 |
| % Margin | 16.7% | 18.8% | 18.8% | 19.2% |
| R&D Expenses | $764 | $782 | $819 | $875 |
| G&A Expenses | $568 | $605 | $553 | $476 |
| SG&A Expenses | $3,000 | $3,365 | $6,429 | $6,430 |
| Sales & Mktg Exp. | $2,432 | $2,760 | $5,875 | $5,955 |
| Other Operating Expenses | $5,160 | $4,920 | $1,482 | $1,545 |
| Operating Expenses | $8,924 | $9,066 | $8,730 | $8,850 |
| Operating Income | $3,596 | $5,121 | $5,074 | $4,786 |
| % Margin | 4.8% | 6.8% | 7.2% | 6.9% |
| Other Income/Exp. Net | $11 | -$10 | -$31 | -$63 |
| Pre-Tax Income | $3,608 | $5,110 | $5,043 | $4,723 |
| Tax Expense | $607 | $851 | $790 | $754 |
| Net Income | $2,835 | $4,056 | $3,967 | $3,720 |
| % Margin | 3.8% | 5.4% | 5.6% | 5.4% |
| EPS | 1.74 | 2.49 | 2.44 | 2.29 |
| % Growth | -30.1% | 2% | 6.6% | – |
| EPS Diluted | 1.74 | 2.49 | 2.44 | 2.29 |
| Weighted Avg Shares Out | 1,626 | 1,626 | 1,626 | 1,626 |
| Weighted Avg Shares Out Dil | 1,626 | 1,626 | 1,626 | 1,626 |
| Supplemental Information | – | – | – | – |
| Interest Income | $404 | $486 | $627 | $564 |
| Interest Expense | $418 | $470 | $434 | $418 |
| Depreciation & Amortization | $875 | $929 | $794 | $721 |
| EBITDA | $4,901 | $6,458 | $6,271 | $5,760 |
| % Margin | 6.5% | 8.6% | 8.9% | 8.3% |